Filing metadata

Accession number
0001104659-18-074905
Form type
Form 4
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Dec 27, 2018
Reporting period
Dec 24, 2018
Description
Insider transaction

Explore SEC Filings Hub